Rosemont Pharmaceuticals Limited – Trademark Portfolio
Entity Type: 99
Rosemont Pharmaceuticals Limited holds 39 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 39 filings in this category. Currently, 29 trademarks are registered and 10 are pending. Notable registered marks include AZLOYO, EMVOWA, AQVESIA, ATMEDLI, and ATMEKSI. The owner is based in Leeds.
Rosemont House, Yorkdale Industrial Park
Braithwaite Street
Leeds LS119XE
Showing of trademarks Trademarks
Trademark Classifications
Rosemont Pharmaceuticals Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Rosemont Pharmaceuticals Limited have?
Rosemont Pharmaceuticals Limited has 39 U.S. trademarks filed with the USPTO. Of these, 29 registered, 10 pending.
What trademark classes does Rosemont Pharmaceuticals Limited file in?
Rosemont Pharmaceuticals Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Rosemont Pharmaceuticals Limited's most well-known trademarks?
Rosemont Pharmaceuticals Limited's registered trademark portfolio includes well-known marks such as AZLOYO, EMVOWA, AQVESIA, ATMEDLI, and ATMEKSI. These are among 29 currently registered trademarks in the portfolio.
What is Rosemont Pharmaceuticals Limited's trademark registration success rate?
Rosemont Pharmaceuticals Limited has a 100% trademark registration rate, with 29 out of 29 resolved applications resulting in successful registration. Currently, 10 applications are pending review.